Fibrosis of the Median Nerve after Radiation Treatments

Li Liu, MD
Last Modified: November 1, 2001

Share article


Question
Dear OncoLink "Ask the Experts,"
Eleven years ago, I had radiation to the neck area. I now have numbness in my right hand and wrist due to scare tissue pinching the median nerve in the neck. Is there any solution to this problem?  
Thank you.


Answer
Li Liu, MD, OncoLink Editorial Assistant, responds:

Thank you for your interest and question.

It is impossible to make recommendations without knowing the detailed history, including diagnosis, stage of disease, radiation field, daily and total dose of radiation, surgery, chemotherapy, and other medical conditions.

The median nerve comes off the brachial plexus near the shoulder. Nerve roots from cervical spine C5 through C8 and the first thoracic vertebra form the brachial plexus. Compression and/or damage of median nerve has unique clinical pictures, represented as numbness and loss of flexion of wrist, thumb, index, and middle finger, thumb opposition, and atrophy of the eminence (ball of thumb) if the damage is long enough.

Fibrosis (scar) is one of the most common long-term radiation side effects. It is time, dose (both total dose and daily dose), and site dependent. Peripheral nerves, such as the median nerve have relatively high radiation tolerance. Crippling, deforming or adhesion of skin and/or soft tissue causes the dysfunction of nerves the majority of time. Physical therapy and occupational therapy may play roles in this setting. If the nerve itself is not damaged, then surgical decompression may be helpful.

It is always important to rule out other causes, such as recurrent cancer, connective tissue disease, diabetes, infection, or medication induced neuropathy. A MRI of the brachial plexus may be helpful in diagnosing the problem. You should talk to your doctor about your problem.


News
Studies outline new options for the standard treatment of various lymphoma types

Dec 7, 2010 - Rituximab may be a better option than watchful waiting in some lymphoma patients, and a new treatment option appears effective for relapsed or refractory Hodgkin's lymphoma, according to two studies being presented at the annual meeting of the American Society of Hematology, held from Dec. 4 to 7 in Orlando, Fla. Other research being presented will highlight new options for the standard treatment of advanced asymptomatic follicular lymphoma; mantle cell lymphoma; and early, unfavorable Hodgkin's disease.



I Wish You Knew

Understanding prostate cancer screening

View More



Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.




OncoLink OncoPilot

Facing a new cancer diagnosis or changing the course of your current treatment? Let our cancer nurses help you through!

Learn More